Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant activated protein C for severe sepsis. - Bernard,G.R.; Vincent,J.L.; Laterre,P.F. (New England Journal of Medicine, 2001)